TerraPower Cancer Isotope Manufacturing Facility
Sector: Manufacturing (Industrial) • Location: Philadelphia, Pennsylvania, United States
Source: Lower Bucks Times
TerraPower Isotopes, backed by Bill Gates, plans to build a $450 million manufacturing facility in South Philadelphia's Bellwether District to produce actinium-225, a rare radioactive isotope used in targeted alpha therapy for cancer treatment. The facility will create 225 full-time jobs and about 500 temporary construction jobs, with operations scheduled to start in 2029.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | TerraPower Isotopes, backed by Bill Gates, plans to build a $450 million manufacturing facility in South Philadelphia's Bellwether District to produce actinium-225, a rare radioactive isotope used in targeted alpha therapy for cancer treatment. The facility will create 225 full-time jobs and about 500 temporary construction jobs, with operations scheduled to start in 2029. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |